This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Japan to issue compliance order against Takeda Pharmaceutical for drug advertisements

( May 22, 2015, 06:07 GMT | Insight) -- MLex Summary: The Japanese government will issue a compliance order against Takeda Pharmaceutical for past advertisements that exaggerated the effects of blood-pressure drug Blopress, public broadcaster NHK reported on its website. The Ministry of Health, ...MLex Summary: The Japanese government will issue a compliance order against Takeda Pharmaceutical for past advertisements that exaggerated the effects of blood-pressure drug Blopress, public broadcaster NHK reported on its website. The Ministry of Health, Labor and Welfare will order the company as early as next month to take corrective measures. The company in March last year issued an apology saying that some parts of the advertisements had been inappropriate, according to NHK....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections